JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-R) Ending Cash Position: ฿42.8 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:JSP-R JSP Pharmaceutical Manufacturing (Thailand) PCL BKK:JSP-R
82 GF Score
Price ฿1.75
GF Value ฿2.18
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is JSP Pharmaceutical Manufacturing (Thailand) PCL Ending Cash Position?

JSP Pharmaceutical Manufacturing (Thailand) PCL BKK:JSP-R +0.32% 82 Ending Cash Position is ฿42.8 Mil as of Jun. 2026. GuruFocus rates BKK:JSP-R with a GF Score™ of 82/100 and a GF Value™ of ฿2.18 (Modestly Undervalued). The stock has 7 warning signs investors should review.

JSP Pharmaceutical Manufacturing (Thailand) PCL's Ending Cash Position for the quarter that ended in Jun. 2026 was ฿42.8 Mil.

JSP Pharmaceutical Manufacturing (Thailand) PCL's quarterly Ending Cash Position declined from Dec. 2025 (฿48.0 Mil) to Mar. 2026 (฿46.4 Mil) and declined from Mar. 2026 (฿46.4 Mil) to Jun. 2026 (฿42.8 Mil).

JSP Pharmaceutical Manufacturing (Thailand) PCL's annual Ending Cash Position increased from Dec. 2023 (฿20.7 Mil) to Dec. 2024 (฿29.5 Mil) and increased from Dec. 2024 (฿29.5 Mil) to Dec. 2025 (฿48.0 Mil).

JSP Pharmaceutical Manufacturing (Thailand) PCL Ending Cash Position Related Terms

JSP Pharmaceutical Manufacturing (Thailand) PCL Ending Cash Position Historical Data

* Premium members only.

The historical data trend for JSP Pharmaceutical Manufacturing (Thailand) PCL's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JSP Pharmaceutical Manufacturing (Thailand) PCL Ending Cash Position Chart

JSP Pharmaceutical Manufacturing (Thailand) PCL Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial 623.91 100.20 20.65 29.49 48.03

JSP Pharmaceutical Manufacturing (Thailand) PCL Quarterly Data
Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37.23 58.16 48.03 46.44 42.84
BKK:JSP-R
82GF Score
JSP Pharmaceutical Manufacturing (Thailand) PCL BKK:JSP-R
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

JSP Pharmaceutical Manufacturing (Thailand) PCL Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

JSP Pharmaceutical Manufacturing (Thailand) PCL's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=29.49+18.541
=48.0

JSP Pharmaceutical Manufacturing (Thailand) PCL's Ending Cash Position for the quarter that ended in Jun. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=46.441+-3.602
=42.8

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of ฿42.8 Mil mean?
JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-R) has a Ending Cash Position of ฿42.8 Mil as of Jun. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on JSP Pharmaceutical Manufacturing (Thailand) PCL and its competitors.
Is JSP Pharmaceutical Manufacturing (Thailand) PCL's Ending Cash Position too high?
JSP Pharmaceutical Manufacturing (Thailand) PCL's current Ending Cash Position is ฿42.8 Mil. Overall, JSP Pharmaceutical Manufacturing (Thailand) PCL has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JSP Pharmaceutical Manufacturing (Thailand) PCL's Ending Cash Position compare to KHC and GIS?
JSP Pharmaceutical Manufacturing (Thailand) PCL's Ending Cash Position of ฿42.8 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Consumer Packaged Goods company?
A good Ending Cash Position depends on the Consumer Packaged Goods industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on JSP Pharmaceutical Manufacturing (Thailand) PCL and its competitors. JSP Pharmaceutical Manufacturing (Thailand) PCL's current Ending Cash Position is ฿42.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JSP Pharmaceutical Manufacturing (Thailand) PCL stock overvalued right now?
Based on GuruFocus' analysis, JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-R) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿2.18, compared to a current price of ฿1.75 — trading 19.9% below its estimated fair value. The current Ending Cash Position is ฿42.8 Mil. JSP Pharmaceutical Manufacturing (Thailand) PCL's overall GF Score™ is 82/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-R), the current Ending Cash Position is ฿42.8 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is JSP Pharmaceutical Manufacturing (Thailand) PCL (BKK:JSP-R) Overvalued in 2026?

Based on GuruFocus' analysis, JSP Pharmaceutical Manufacturing (Thailand) PCL stock appears to be undervalued. The current stock price of ฿1.75 is trading 19.9% below its estimated GF Value™ of ฿2.18. GuruFocus considers JSP Pharmaceutical Manufacturing (Thailand) PCL to be Modestly Undervalued.

Key valuation signals for BKK:JSP-R:

  • Ending Cash Position: ฿42.8 Mil
  • GF Value™: ฿2.18 vs. price of ฿1.75 (19.9% below fair value)
  • GF Score™: 82/100 with 7 warning signs

No single metric tells the full story. See the BKK:JSP-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

JSP Pharmaceutical Manufacturing (Thailand) PCL Business Description

Other Exchanges JSP:Thailand
Address No. 255, 257 Soi Sathupradit 58, Bang Pongphang, Yan Nawa, Bangkok, THA, 10120
JSP Pharmaceutical Manufacturing (Thailand) PCL is engaged in producing modern medicine, traditional medicine, herbal products, dietary supplements, medical supplies, and cleaning alcohol under the client's and the company's own trademarks. Maximum revenue for the company is generated from the sale of dietary supplements. The Group's reportable operating segments are: Manufacture and distribution of products under the company's brand name (Own brands), which generate maximum revenue, Manufacture and distribution of products under customers' brand name (OEM), Manufacture and distribution of hemodialysis solution and related medical supplies; and Service, research and development, and healthcare products training. Geographically, it operates principally in Thailand.
82GF Score

Get the complete analysis for BKK:JSP-R

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿1.75
Price
฿2.18
GF Value